Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 211 Results August 1, 2023 Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates June 28, 2023 Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market May 15, 2023 Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates May 10, 2023 Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia May 8, 2023 Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023 May 1, 2023 Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia March 8, 2023 Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates March 1, 2023 Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023 December 28, 2022 Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia November 9, 2022 Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates «12345...1020...»